¼¼°èÀÇ Ã¼Çü °³¼± ÇÊ·¯ ½ÃÀå
Body Augmentation Fillers
»óǰÄÚµå : 1777878
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 370 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Ã¼Çü °³¼± ÇÊ·¯ ½ÃÀåÀº 2030³â±îÁö 30¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â üÇü °³¼± ÇÊ·¯ ¼¼°è ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 18.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 30¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ È÷¾Ë·ç·Ð»êÀº CAGR20.3%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 20¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ä®½· ÇÏÀ̵å·Ï½Ç ¾ÆÆÄŸÀÌÆ® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 16.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 130¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR24.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ã¼Çü °³¼± ÇÊ·¯ ½ÃÀåÀº 2024³â¿¡ 3¾ï 130¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 9,060¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 24.5%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, °¢°¢ ºÐ¼® ±â°£ Áß¿¡ 13.4%¿Í 16.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.7%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ Ã¼Çü °³¼± ÇÊ·¯ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

üÇü °³¼± ÇÊ·¯ ½ÃÀåÀ» ÁÖµµÇÏ´Â ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?

üÇü °³¼± ÇÊ·¯ ½ÃÀåÀº Á¦Ç°ÀÇ È¿°ú, ¾ÈÀü¼º, ¼ö¸í Çâ»óÀ» À§ÇÑ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀ¸·Î Å©°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ¶Ù¾î³­ »ýüÀûÇÕ¼º°ú º¸½À·ÂÀ¸·Î À¯¸íÇÑ È÷¾Ë·ç·Ð»ê(HA) ±â¹Ý ÇÊ·¯ÀÇ ±â¼ú Çõ½ÅÀÌ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϰí ÀÚ¿¬½º·¯¿î ¸¶¹«¸®¸¦ Á¦°øÇÕ´Ï´Ù. Ä®½·ÇÏÀ̵å·Ï½Ç¾ÆÆÄŸÀÌÆ®, Æú¸®-L-¶ôÆ®»ê, Æú¸®¸ÞÆ¿¸ÞŸũ¸±·¹ÀÌÆ®(PMMA)¿Í °°Àº ºñ HA ÇÊ·¯´Â ±× È¿°ú°¡ ´õ ¿À·¡ Áö¼ÓµÇ°í Äݶó°Õ »ý¼ºÀ» ÀÚ±ØÇÏ´Â ´É·ÂÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÷´Ü °¡±³ ±â¼úÀÇ °³¹ß·Î ÇÊ·¯ÀÇ Á¡¼º°ú ź¼ºÀÌ °³¼±µÇ¾î ³»±¸¼ºÀÌ Çâ»óµÇ°í ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ¿­È­À²ÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ¿¬Àû Á¶Á÷ Àç»ýÀ» ÃËÁøÇÏ´Â »ýü Àڱؼº ÇÊ·¯ÀÇ µîÀåÀº ½ÃÀåÀ» ÀçÆíÇϰí Àå±âÀûÀÎ ¹Ì¿ë È¿°ú¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î ij´¼¶ó ÁÖ»ç¿Í °°Àº ±â¼úÀº Ç÷°ü ÇÕº´ÁõÀÇ À§ÇèÀ» ÁÙÀ̰í ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­ÇÏ¿© ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. Á¤¹ÐÇÑ Åõ¾à ±â´ÉÀ» °®Ãá ½º¸¶Æ® ÁÖ»ç±âµµ µµÀԵǾî ÀϰüµÈ Àû¿ëÀ» º¸ÀåÇÏ°í ½Ã¼úÀÇ À§ÇèÀ» ÁÙ¿´½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Ä¡·á °á°ú¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, ¾ó±¼ À±°û ¼ºÇü¿¡¼­ ºñ¼ö¼úÀû ½Åü ¼ºÇü±îÁö üÇü °³¼± ÇÊ·¯ÀÇ Àû¿ë ¹üÀ§¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

¹ÌÀû ÃëÇâÀÇ º¯È­¿Í ÃÖÁ¾ »ç¿ëÀÚ Æ®·»µå°¡ üÇü °³¼± ÇÊ·¯ ¼ö¿ä¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

üÇü °³¼± ÇÊ·¯¿¡ ´ëÇÑ ¼ö¿ä´Â ¹ÌÀû ÃëÇâÀÇ º¯È­¿Í ºñ¼ö¼úÀû ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ë¼º Áõ°¡¿¡ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº ÀÚ¿¬½º·¯¿ì¸é¼­µµ ȸº¹±â°£ÀÌ Âª°í, ÃÖ¼Òħ½ÀÀûÀÎ ½Ã¼úÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ¼Ò¼È ¹Ìµð¾îÀÇ ¹ß´Þ°ú ÀÎÇ÷ç¾ð¼­³ª À¯¸íÀεéÀÌ È«º¸ÇÏ´Â ¹ÌÀÇ ±âÁØÀÇ ¿µÇâÀ¸·Î Èü¾÷, Á¾¾Æ¸® ¼ºÇü, ¼Õ ȸÃá µî ½Åü À±°ûÀ» ´Ùµë´Â ½Ã¼ú¿¡ ´ëÇÑ ¿å±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Àα¸ Åë°èÇÐÀûÀ¸·Îµµ ÀþÀº ÃþÀº ¿¹¹æÀû ¹Ì¿ë Ä¡·á¸¦ ¼±ÅÃÇϰí, ³ë³âÃþÀº ¾ÈƼ¿¡ÀÌ¡À» À§ÇÑ ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. ÀÇ·á&¹Ì¿ë Ŭ¸®´Ð¿¡¼­´Â ÇÊ·¯¿Í ·¹ÀÌÀú, °íÁÖÆÄ Ä¡·á µî ¿¡³ÊÁö ±â¹Ý Àåºñ¸¦ ÅëÇÕÇÑ ÄÞºñ³×ÀÌ¼Ç Ä¡·á°¡ Àα⸦ ²ø°í ÀÖÀ¸¸ç, Á¾ÇÕÀûÀΠȸÃá È¿°ú¸¦ Á¦°øÇÕ´Ï´Ù. °³°³ÀÎÀÇ ¾ó±¼ ÇØºÎÇÐÀû ±¸Á¶¿Í ¹ÌÀû ¸ñÇ¥¿¡ µû¸¥ ¸ÂÃãÇü Ä¡·á °èȹ¿¡ ´ëÇÑ ¼ö¿ä°¡ ¸ÂÃãÇü ÇÊ·¯ Á¦Á¦ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Çѱ¹, ºê¶óÁú, ű¹°ú °°Àº Áö¿ª¿¡¼­ÀÇ ÀÇ·á °ü±¤ÀÇ ¼ºÀåÀº ½Åü °­È­ ÇÊ·¯ Ä¡·áÀÇ ¼¼°è ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¾ÈÀüÇϰí È¿°úÀûÀ̸ç ÃÖ¼Òħ½ÀÀûÀÎ ½Ã¼ú¿¡ ´ëÇÑ ÃÖÁ¾ »ç¿ëÀÚµéÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½Åü °­È­ ÇÊ·¯ ½ÃÀå ¿ªÇÐÀÌ ÀçÆíµÇ°í ÀÖ½À´Ï´Ù.

½Åü °­È­ ÇÊ·¯ »ê¾÷¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±ÔÁ¦¿Í ½ÃÀå ¿ªÇÐÀº ¹«¾ùÀΰ¡?

½Åü °­È­ ÇÊ·¯ »ê¾÷Àº Á¦Ç°ÀÇ ¾ÈÀü¼º, À¯È¿¼º, À±¸®Àû ¸¶ÄÉÆÃÀ» º¸ÀåÇϱâ À§ÇØ °í¾ÈµÈ º¹ÀâÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¾È¿¡¼­ ¿î¿µµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ FDA, À¯·´ÀǾàǰû(EMA) µî ±ÔÁ¦±â°üÀº ºÎÀÛ¿ë°ú Á¦Ç° ¼º´ÉÀ» ¸ð´ÏÅ͸µÇϱâ À§ÇØ ¾ö°ÝÇÑ ÀÓ»ó½ÃÇè°ú ½ÃÆÇ ÈÄ Á¶»ç¸¦ Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. Á¦Ç°ÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÇÊ·¯ÀÇ ¼ººÐ, ÁÖÀÔ ±â¼ú, ½Ã¼úÀÚÀÇ ÀÚ°Ý¿¡ ´ëÇÑ °¨½ÃÀÇ ´«Ãʸ®°¡ ´õ¿í ¾ö°ÝÇØÁö°í ÀÖ½À´Ï´Ù. ½ÃÀå ¿ªÇÐÀº ¶ÇÇÑ À§Á¶Ç° ¹× ºñ±ÔÁ¦ ÇÊ·¯ Á¦Ç° Áõ°¡·Î ÀÎÇØ ¿µÇâÀ» ¹Þ°í ÀÖÀ¸¸ç, ¾ÈÀüÇÑ °üÇàÀ» ÃËÁøÇϱâ À§ÇØ ´õ ¾ö°ÝÇÑ ´Ü¼Ó Á¶Ä¡¿Í ±³À° Ä·ÆäÀÎÀ» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. Á¦Ç°ÀÇ ÁøÀ§ ¿©ºÎ¿Í Ä¡·á À§Çè¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ °øÀÎµÈ ÀÇ·á½Ã¼³¿¡¼­ °øÀÎµÈ Àü¹®ÀÇÀÇ Ä¡·á¸¦ ¹ÞÀ¸·Á´Â ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °æÀï»óȲÀÇ Æ¯Â¡Àº Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ÅõÀÚ·Î, °¢ ¾÷üµéÀº Àå¼ö¸íÈ­, ¸é¿ª¿ø¼º °¨¼Ò, ȯÀÚ ¸¸Á·µµ Çâ»óÀ» ½ÇÇöÇÑ Â÷¼¼´ë ÇÊ·¯ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾àȸ»ç¿Í ¹Ì¿ë Ŭ¸®´Ð°úÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ°í ½ÃÀå Á¢±Ù¼ºÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¿Í ½ÃÀåÀÇ ÈûÀº ¾ÈÀü¼º, À¯È¿¼º, À±¸®Àû °üÇàÀ» Áß½ÃÇϴ üÇüº¸°­ ÇÊ·¯ »ê¾÷ÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

½Åü °­È­ ÇÊ·¯ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

üÇü °³¼± ÇÊ·¯ ½ÃÀåÀÇ ¼ºÀåÀº ÇÊ·¯ ±â¼úÀÇ ¹ßÀü, ¹ÌÀû °¨°¢ Áõ°¡, ÃÖ¼Òħ½ÀÀû ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. »ýü Àڱؼº ÇÊ·¯¿Í ÷´Ü °¡±³ ±â¼ú µîÀÇ ±â¼ú Çõ½ÅÀº Á¦Ç° ¼º´É°ú Ä¡·á ¼ö¸íÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¹æÀû Ä¡·á¸¦ ¿øÇÏ´Â ÀþÀº Ãþ°ú ¾ÈƼ¿¡ÀÌ¡ ¼Ö·ç¼ÇÀ» ¿øÇÏ´Â ³ë³âÃþÀÇ Àα¸ ±â¹ÝÀÌ È®´ëµÇ¸é¼­ ½ÃÀå ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¼Ò¼È ¹Ìµð¾îÀÇ ¿µÇâ, À¯¸íÀÎ ¹®È­, ¹Ì¿ë °­È­¿¡ ´ëÇÑ ¼ö¿ëÀÇ È®´ë´Â ¹Ì¿ë ½Ã¼úÀ» Á¤»óÈ­ÇÏ°í ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ÇÊ·¯ Á¦Ç°ÀÇ ±ÔÁ¦ ½ÂÀΰú ÀûÀÀÁõ È®´ëµµ Àü ¼¼°èÀûÀ¸·Î º¸±Þ·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á°ü±¤ Áõ°¡´Â ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ß´ÞÇÏ°í ºñ¿ë ´ëºñ È¿°ú°¡ ³ôÀº Áö¿ª¿¡¼­ ½Ã¼ú °Ç¼ö¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç, ºäƼ Ŭ¸®´Ð, KOL(Key Opinion Leader) °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ Á¦Ç° Çõ½ÅÀ» ÃËÁøÇÏ°í ½ÃÀå µµ´Þ ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº Áö¼ÓÀûÀÎ R&D ÅõÀÚ¿Í ¹Ì¿ëÄ¡·á¿¡ ´ëÇÑ ÀÎ½Ä °³¼±°ú ÇÔ²² üÇü °³¼± ÇÊ·¯ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå°ú ¼¼°è È®ÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(È÷¾Ë·ç·Ð»ê, ÇÏÀ̵å·Ï½Ã ¾îÆÛŸÀÌÆ® Ä®½·, Æú¸® ¸ÞŸũ¸±»ê¸ÞÆ¿, Æú¸®Ä«ÇÁ·Î¶ôÅæ), ÇÁ¸®ÇÊµå ½Ã¸°Áö À¯Çü(£¼5ml ½Ã¸°Áö, 10ml ½Ã¸°Áö, 20ml ½Ã¸°Áö), ¿ëµµ(¼Õ ȸÃá ¿ëµµ, À¯¹æ È®´ë ¿ëµµ, ¾ûµ¢ÀÌ È®´ë ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÀÎÅ×±×·¹À̼ÇÁî

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå°ú °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Body Augmentation Fillers Market to Reach US$3.0 Billion by 2030

The global market for Body Augmentation Fillers estimated at US$1.1 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 18.4% over the analysis period 2024-2030. Hyaluronic Acid, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Calcium Hydroxylapatite segment is estimated at 16.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$301.3 Million While China is Forecast to Grow at 24.5% CAGR

The Body Augmentation Fillers market in the U.S. is estimated at US$301.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$690.6 Million by the year 2030 trailing a CAGR of 24.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.4% and 16.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Body Augmentation Fillers Market - Key Trends & Drivers Summarized

What Are the Technological Innovations Driving the Body Augmentation Fillers Market?

The body augmentation fillers market has evolved significantly with continuous technological advancements aimed at improving product efficacy, safety, and longevity. Innovations in hyaluronic acid (HA)-based fillers, known for their superior biocompatibility and hydration properties, are at the forefront, providing natural-looking results with minimal side effects. Non-HA fillers, such as calcium hydroxylapatite, poly-L-lactic acid, and polymethyl methacrylate (PMMA), are gaining popularity for their longer-lasting effects and ability to stimulate collagen production. The development of advanced cross-linking technologies has improved filler viscosity and elasticity, enhancing durability and reducing degradation rates over time. Additionally, the emergence of bio-stimulatory fillers that promote natural tissue regeneration is reshaping the market, offering long-term aesthetic benefits. Techniques like microcannula injections have improved safety by reducing the risk of vascular complications and minimizing patient discomfort. Smart injectable devices with precision dosing capabilities are also being introduced, ensuring consistent application and reducing procedural risks. These innovations are not only enhancing treatment outcomes but also broadening the application spectrum of body augmentation fillers, from facial contouring to non-surgical body sculpting procedures.

How Are Changing Aesthetic Preferences and End-Use Trends Impacting Demand for Body Augmentation Fillers?

The demand for body augmentation fillers is being influenced by shifting aesthetic preferences and the growing acceptance of non-surgical cosmetic procedures. Consumers are increasingly seeking minimally invasive treatments that offer natural-looking enhancements with shorter recovery times. The rise of social media and the influence of beauty standards promoted by influencers and celebrities have fueled the desire for body contouring procedures, including buttock augmentation, calf shaping, and hand rejuvenation. The demographic landscape is also expanding, with younger individuals opting for preventative aesthetic treatments and older populations seeking anti-aging solutions. In medical aesthetics clinics, combination therapies that integrate fillers with energy-based devices, such as lasers and radiofrequency treatments, are gaining traction, providing comprehensive rejuvenation outcomes. The demand for personalized treatment plans tailored to individual facial anatomy and aesthetic goals is driving the development of customized filler formulations. Additionally, the growth of medical tourism in regions like South Korea, Brazil, and Thailand is expanding the global reach of body augmentation filler treatments. This shift in end-user preferences towards safe, effective, and minimally invasive procedures is reshaping the dynamics of the body augmentation fillers market.

What Regulatory and Market Dynamics Are Influencing the Body Augmentation Fillers Industry?

The body augmentation fillers industry operates within a complex regulatory framework designed to ensure product safety, efficacy, and ethical marketing practices. Regulatory agencies such as the U.S. FDA, EMA (European Medicines Agency), and others require stringent clinical trials and post-market surveillance to monitor adverse events and product performance. The growing focus on product safety has led to increased scrutiny over filler compositions, injection techniques, and practitioner qualifications. Market dynamics are also being influenced by the rise of counterfeit and unregulated filler products, prompting stricter enforcement measures and educational campaigns to promote safe practices. Consumer awareness regarding product authenticity and treatment risks has increased, driving demand for treatments administered by board-certified professionals in accredited medical facilities. The competitive landscape is characterized by continuous R&D investments, with companies focusing on developing next-generation fillers with enhanced longevity, reduced immunogenicity, and improved patient satisfaction. Additionally, strategic collaborations between pharmaceutical companies and aesthetic clinics are fostering innovation and expanding market access. These regulatory and market forces are shaping the future of the body augmentation fillers industry, emphasizing safety, efficacy, and ethical practices.

The Growth in the Body Augmentation Fillers Market Is Driven by Several Factors…

The growth in the body augmentation fillers market is driven by several factors, including advancements in filler technologies, rising aesthetic consciousness, and increasing demand for minimally invasive cosmetic procedures. Technological innovations, such as bio-stimulatory fillers and advanced cross-linking techniques, are enhancing product performance and treatment longevity. The expanding demographic base, driven by younger individuals seeking preventative treatments and older populations pursuing anti-aging solutions, is fueling market demand. The influence of social media, celebrity culture, and the growing acceptance of cosmetic enhancements have normalized aesthetic procedures, further accelerating market growth. Regulatory approvals for new filler products and expanded indications are also driving adoption rates globally. Additionally, the rise of medical tourism, particularly in cost-effective regions with advanced healthcare infrastructure, is boosting procedural volumes. Strategic partnerships between pharmaceutical companies, aesthetic clinics, and key opinion leaders are fostering product innovation and expanding market reach. These factors, combined with continuous R&D investments and increasing awareness of aesthetic treatments, are propelling the body augmentation fillers market toward sustained growth and global expansion.

SCOPE OF STUDY:

The report analyzes the Body Augmentation Fillers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Hyaluronic Acid, Calcium Hydroxylapatite, Polymethylmethacrylate and Polycaprolactone); Pre-Filled Syringes Type (<5 ml Syringes, 10 ml Syringes, 20 ml Syringes); Application (Hand Rejuvenation Application, Breast Augmentation Application, Buttock Augmentation Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â